載入...
P2Y12 inhibitors: do they increase cancer risk?
Treatment with dual antiplatelet therapy (DAPT), typically combining a P2Y12 inhibitor with aspirin, is the standard of care for the prevention of coronary stent thrombosis, especially post revascularization and in the setting of acute coronary syndromes (ACS). Determining the appropriate duration h...
Na minha lista:
| 發表在: | Ann Transl Med |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787374/ https://ncbi.nlm.nih.gov/pubmed/31660308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.07.90 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|